Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults.
Felicia CaoYueling XiuMichael MohnaskyJonathan S SerodyPaul ArmisteadGianpietro DottiMelody SmithJonathan P HugginsJulia A MessinaBhanu RamachandranJennifer L SaulloJoseph StrombergManish K SahaMegan WalshBarbara SavoldoNatalie Sophia GroverHeather I HendersonTessa M AndermannPublished in: medRxiv : the preprint server for health sciences (2024)
1) The incidence of infections within the first year after CD30.CAR T-cell therapy was equivalent to that following CD19.CAR T-cell therapy2) Viral infections were more common after CD30.CAR T-cell therapy but bacterial infections predominated after CD19.CAR T-cell therapy.